Immune checkpoint inhibitor efficacy against glioblastoma may decrease with dexamethasone ...Middle East

- News
Immune checkpoint inhibitor efficacy against glioblastoma may decrease with dexamethasone
Among patients with glioblastoma receiving an immune checkpoint inhibitor, those who received the corticosteroid dexamethasone at baseline for cerebral edema had significantly worse overall survival.

Hence then, the article about immune checkpoint inhibitor efficacy against glioblastoma may decrease with dexamethasone was published today ( ) and is available on ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Immune checkpoint inhibitor efficacy against glioblastoma may decrease with dexamethasone )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News